id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2959706,1622b3fe-0fac-4cee-9f4b-e0f2ec935cba,Q1,TIBER CREEK GROUP,20744,"BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)",2023,first_quarter,HCR,"Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA, Consolidated Appropriations Act, 2023 (PL 117-328).","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2023-04-14T16:00:28-04:00
2959707,1622b3fe-0fac-4cee-9f4b-e0f2ec935cba,Q1,TIBER CREEK GROUP,20744,"BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)",2023,first_quarter,MMM,"Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing).","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2023-04-14T16:00:28-04:00
2959708,1622b3fe-0fac-4cee-9f4b-e0f2ec935cba,Q1,TIBER CREEK GROUP,20744,"BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)",2023,first_quarter,MAN,Issues relating to US and international manufacturing.,"Commerce, Dept of (DOC),Treasury, Dept of",70000,,0,0,2023-04-14T16:00:28-04:00